Tamtam Try Tamtam free
Yale New Haven Health logo

Yale New Haven Health account plan

Provide advanced medical care

At a glance

Yale New Haven Health is a not-for-profit Connecticut health system of five hospitals with FY2025 operating revenue of $7,579.6 million.

Yale New Haven Health System is a not-for-profit integrated regional healthcare delivery system formed in 1983, coordinating Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital, Lawrence + Memorial and Westerly hospitals, the Northeast Medical Group physician organization, home care and urgent care in Connecticut, New York, Rhode Island and Massachusetts. In the fiscal year ended September 30, 2025 total operating revenue was $7,579.6 million, including $6,423.1 million of patient service revenue and $988.3 million of pharmacy sales. It posted an operating loss of $196.8 million after restructuring, but an excess of revenue over expenses of $91.3 million thanks to nonoperating gains; net assets were $4,813.0 million. The statements give no headcount.

Business units

Strategic priorities

Return to operating surplus
Management expects to return to positive operating results in fiscal 2026 with a projected $50 million surplus, after an operating loss of $196.8 million in FY2025.
Operating model redesign
A March 2025 redesign restructured inpatient and ambulatory operations and consolidated management and administrative roles to speed decisions.
Workforce cost reduction
A voluntary retirement program drew 600 acceptances; the System expects to hire about 400 replacements and save about $50 million.
Ambulatory and urgent care expansion
The board has provided seed money to expand urgent and ambulatory care into central Connecticut.
Complete major projects
The 505,000-square-foot Neurosciences Center in New Haven and the $75 million Connecticut Proton Therapy Center in Wallingford are expected to complete in 2026.

Investments and deals

Capital program
Property, plant and equipment acquisitions were $464.1 million in FY2025, and construction in progress rose to $659.8 million; remaining commitments were about $172.1 million for the neuroscience tower and $183.4 million for other projects.
Connecticut Proton Therapy Center
A $75 million, 25,000-square-foot center in Wallingford developed jointly with Hartford HealthCare.
Exit from the Prospect hospitals deal
The System paid Prospect Medical Holdings $45.0 million in October 2025 to terminate its agreement to acquire three Connecticut hospitals.
Restructuring
FY2025 included $57.7 million of severance payments and vendor-contract termination costs.

Challenges and risks

Operating losses
Operating income before depreciation, interest and restructuring fell to $160.3 million from $286.3 million, and the System has had deficits in three of the last four fiscal years.
Rising costs and low reimbursement
Drug and equipment costs keep rising while Medicare and Medicaid reimbursement remains low and federal research funding and ACA subsidies shrink.
Safety-net burden
Uncompensated care cost approximately $98.1 million in FY2025, and the System paid $316.8 million into the Connecticut DSH assessment.
Cybersecurity
A March 2025 data breach affected about 5.6 million patients and led to an $18 million settlement.
Rating pressure
S&P kept its AA- rating with a negative outlook, citing operating losses and large construction projects including an $838 million neuroscience tower.

What leadership says

“The headwinds are strong”

Christopher O'Connor, CEO (until June 2026) · Interview with the Hartford Business Journal, December 1, 2025

“I'm confident in the steps that we've taken that we will hit our budget this year and continue that stabilization journey”

Christopher O'Connor, CEO (until June 2026) · Interview with the Hartford Business Journal, December 1, 2025

“The board has already given us the seed money necessary to initiate that work. So we are absolutely going to continue our ambulatory expansion.”

Christopher O'Connor, CEO (until June 2026) · Interview with the Hartford Business Journal, December 1, 2025

Where a supplier can help

Cost and supply savings
With supplies and other costs at $3,638.1 million and a target to return to surplus in fiscal 2026, procurement, pharmacy and cost-reduction offerings fit.
Ambulatory and urgent care rollout
The central Connecticut ambulatory expansion needs site development, equipment, scheduling and patient-access technology.
Cybersecurity after the breach
The data breach affecting about 5.6 million patients makes security, identity and data protection a clear need.
Workforce transition
Hiring about 400 replacements after the voluntary retirement program suits recruiting, onboarding and knowledge-transfer services.
Construction and facility fit-out
The Neurosciences Center and proton therapy projects completing in 2026 open room for medical equipment, fit-out and facility services.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Yale New Haven Health?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Yale New Haven Health

What is Yale New Haven Health?

A not-for-profit integrated healthcare system in Connecticut that coordinates five hospitals, a physician group, home care and urgent care.

What is Yale New Haven Health's revenue?

Total operating revenue was $7,579.6 million in the fiscal year ended September 30, 2025, up from $7,237.3 million.

Is Yale New Haven Health profitable?

It had an operating loss of $196.8 million in FY2025 but an excess of revenue over expenses of $91.3 million after nonoperating gains; management projected a $50 million operating surplus for fiscal 2026.

What is Yale New Haven Health's strategy?

Stabilize finances through an operating model redesign and workforce savings, expand ambulatory and urgent care into central Connecticut, and complete the Neurosciences Center and proton therapy center.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)